The benefit of the combination of serum galactomannan ( GM ) assay and polymerase chain reaction ( PCR ) - based detection of serum Aspergillus DNA for the early diagnosis and therapy of invasive aspergillosis ( IA ) in high-risk hematological patients remains unclear .